Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Latest filing published 09 Jun 2025 for Immunic, INC., €8,630.
Filing timeline
BuySaleJason Tardio
Insider track record
Disclosed buys
2
Disclosed sells
1
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +32.3%Entry US$8.85 · Close at T+365 US$11.71
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jason Tardio: trading record in brief
Jason Tardio discloses dealings in 2 companies, chiefly Immunic, Inc. and Ovid Therapeutics Inc. We count 4 filings; the first trade dates from 12 September 2022 and the latest from 5 June 2025.
Both buying and selling appear: 2 purchases worth €17k, against 1 sale worth €37k. Taken together, the sales exceed the purchases by €20k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. In 2025 alone, the filings show 2 purchases and no sales.
The record was last updated on 20 June 2025 with an open-market purchase (€8,630) in Immunic, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jason Tardio
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
12,512 shares@ US$0.79100.0% of flowCommon StockSEC:0001193805-25-000839:0
Canonical exit: 3 Sept 2025 (T+90)
28,125 shares0Common StockSEC:0001209191-24-003972:0
17,344 shares@ US$2.15100.0% of flowCommon StockSEC:0001209191-22-049938:0
3 of 3 declarations
